Syndax Pharmaceuticals (SNDX) Non Operating Income (2016 - 2020)
Historic Non Operating Income for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q4 2020 value amounting to -$563000.0.
- Syndax Pharmaceuticals' Non Operating Income fell 37463.41% to -$563000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$1.7 million, marking a year-over-year decrease of 21628.69%. This contributed to the annual value of $20.9 million for FY2024, which is 155.39% up from last year.
- According to the latest figures from Q4 2020, Syndax Pharmaceuticals' Non Operating Income is -$563000.0, which was down 37463.41% from -$584000.0 recorded in Q3 2020.
- In the past 5 years, Syndax Pharmaceuticals' Non Operating Income ranged from a high of $563000.0 in Q2 2018 and a low of -$1.6 million during Q1 2016
- Its 5-year average for Non Operating Income is $105900.0, with a median of $298000.0 in 2016.
- Its Non Operating Income has fluctuated over the past 5 years, first surged by 17733.99% in 2018, then crashed by 37463.41% in 2020.
- Syndax Pharmaceuticals' Non Operating Income (Quarter) stood at $326000.0 in 2016, then increased by 18.1% to $385000.0 in 2017, then rose by 28.83% to $496000.0 in 2018, then crashed by 58.67% to $205000.0 in 2019, then crashed by 374.63% to -$563000.0 in 2020.
- Its Non Operating Income was -$563000.0 in Q4 2020, compared to -$584000.0 in Q3 2020 and -$452000.0 in Q2 2020.